Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
57
VRSN Quote, Financials, Valuation and Earnings
Last price:
$280.73
Seasonality move
:
-0.8%
Day range:
$278.71 - $283.40
52-week range:
$172.49 - $291.54
Dividend yield:
0.27%
P/E ratio:
34.63x
P/S ratio:
17.38x
P/B ratio:
--
Volume:
541.4K
Avg. volume:
658.8K
1-year change:
57.55%
Market cap:
$26.6B
Revenue:
$1.6B
EPS (TTM):
$8.18
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.4B | $1.5B | $1.6B | |
| Revenue Growth (YoY) | 2.71% | 4.94% | 7.33% | 4.79% | 4.31% | |
| Cost of Revenues | $180.2M | $191.9M | $200.7M | $197.3M | $191.4M | |
| Gross Profit | $1.1B | $1.1B | $1.2B | $1.3B | $1.4B | |
| Gross Profit Margin | 85.76% | 85.55% | 85.92% | 86.79% | 87.71% | |
| R&D Expenses | $74.7M | $80.5M | $85.7M | $91M | $96.7M | |
| Selling, General & Admin | $186M | $188.4M | $195.4M | $204.2M | $211.1M | |
| Other Inc / (Exp) | $8.4M | -$1.9M | -$2.5M | $5.1M | $1.6M | |
| Operating Expenses | $260.7M | $268.9M | $281.1M | $295.2M | $307.8M | |
| Operating Income | $824.2M | $866.8M | $943.1M | $1B | $1.1B | |
| Net Interest Expenses | $82.3M | $82.7M | $60.4M | $29.2M | $37.9M | |
| EBT. Incl. Unusual Items | $750.2M | $782.2M | $880.2M | $976.5M | $1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$64.6M | -$2.6M | $206.4M | $158.9M | $236.2M | |
| Net Income to Company | $814.9M | $784.8M | $673.8M | $817.6M | $785.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $814.9M | $784.8M | $673.8M | $817.6M | $785.7M | |
| Basic EPS (Cont. Ops) | $7.08 | $7.01 | $6.24 | $7.91 | $8.01 | |
| Diluted EPS (Cont. Ops) | $7.07 | $7.00 | $6.24 | $7.90 | $8.00 | |
| Weighted Average Basic Share | $115.1M | $112M | $107.9M | $103.4M | $98.1M | |
| Weighted Average Diluted Share | $115.3M | $112.2M | $108M | $103.5M | $98.2M | |
| EBITDA | $886.7M | $913.4M | $1B | $1.1B | $1.1B | |
| EBIT | $840.4M | $865.5M | $955.5M | $1.1B | $1.1B | |
| Revenue (Reported) | $1.3B | $1.3B | $1.4B | $1.5B | $1.6B | |
| Operating Income (Reported) | $824.2M | $866.8M | $943.1M | $1B | $1.1B | |
| Operating Income (Adjusted) | $840.4M | $865.5M | $955.5M | $1.1B | $1.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $323.6M | $346.9M | $364.4M | $384.3M | $402.3M | |
| Revenue Growth (YoY) | 3.54% | 7.2% | 5.05% | 5.46% | 4.68% | |
| Cost of Revenues | $47M | $50.7M | $49.9M | $49.1M | $49.4M | |
| Gross Profit | $276.6M | $296.2M | $314.5M | $335.2M | $352.9M | |
| Gross Profit Margin | 85.48% | 85.39% | 86.31% | 87.22% | 87.72% | |
| R&D Expenses | $20.3M | $22.9M | $24.2M | $24.8M | $26M | |
| Selling, General & Admin | $45.9M | $48.5M | $49M | $51.5M | $55.7M | |
| Other Inc / (Exp) | $400K | -- | $600K | $1.9M | -$400K | |
| Operating Expenses | $66.2M | $71.4M | $73.2M | $76.3M | $81.7M | |
| Operating Income | $210.4M | $224.8M | $241.3M | $258.9M | $271.2M | |
| Net Interest Expenses | $22.5M | $18.5M | $8.1M | $6.8M | $12.4M | |
| EBT. Incl. Unusual Items | $188.3M | $206.3M | $233.8M | $254M | $258.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $37.9M | $48.8M | $55.1M | $59.9M | $59.1M | |
| Net Income to Company | $150.4M | $157.5M | $178.7M | $194.1M | $199.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $150.4M | $157.5M | $178.7M | $194.1M | $199.3M | |
| Basic EPS (Cont. Ops) | $1.33 | $1.43 | $1.70 | $1.93 | $2.11 | |
| Diluted EPS (Cont. Ops) | $1.33 | $1.43 | $1.70 | $1.92 | $2.10 | |
| Weighted Average Basic Share | $113.1M | $110.2M | $104.9M | $100.8M | $94.6M | |
| Weighted Average Diluted Share | $113.3M | $110.3M | $105M | $100.9M | $94.8M | |
| EBITDA | $222.4M | $237M | $264.2M | $282.6M | $287.6M | |
| EBIT | $210.8M | $225.1M | $252.6M | $272.8M | $278.7M | |
| Revenue (Reported) | $323.6M | $346.9M | $364.4M | $384.3M | $402.3M | |
| Operating Income (Reported) | $210.4M | $224.8M | $241.3M | $258.9M | $271.2M | |
| Operating Income (Adjusted) | $210.8M | $225.1M | $252.6M | $272.8M | $278.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.4B | $1.4B | $1.5B | $1.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $181.6M | $195.6M | $199.9M | $196.5M | $191.7M | |
| Gross Profit | $1.1B | $1.2B | $1.2B | $1.3B | $1.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $77.6M | $83.1M | $87M | $91.6M | $97.9M | |
| Selling, General & Admin | $188.6M | $191M | $195.9M | $206.7M | $215.3M | |
| Other Inc / (Exp) | $6.1M | -$2.3M | -$1.9M | $6.4M | -$700K | |
| Operating Expenses | $266.2M | $274.1M | $282.9M | $298.3M | $313.2M | |
| Operating Income | $828.3M | $881.2M | $959.6M | $1B | $1.1B | |
| Net Interest Expenses | $86.7M | $78.7M | $50M | $27.9M | $43.5M | |
| EBT. Incl. Unusual Items | $747.7M | $800.2M | $907.7M | $996.7M | $1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $116.6M | $8.3M | $212.7M | $163.7M | $235.4M | |
| Net Income to Company | $631.2M | $791.9M | $695M | $833M | $790.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $631.2M | $791.9M | $695M | $833M | $790.9M | |
| Basic EPS (Cont. Ops) | $5.52 | $7.12 | $6.52 | $8.15 | $8.19 | |
| Diluted EPS (Cont. Ops) | $5.52 | $7.11 | $6.52 | $8.14 | $8.18 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $884.6M | $928M | $1B | $1.1B | $1.1B | |
| EBIT | $837.8M | $879.8M | $983M | $1.1B | $1.1B | |
| Revenue (Reported) | $1.3B | $1.4B | $1.4B | $1.5B | $1.6B | |
| Operating Income (Reported) | $828.3M | $881.2M | $959.6M | $1B | $1.1B | |
| Operating Income (Adjusted) | $837.8M | $879.8M | $983M | $1.1B | $1.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $323.6M | $346.9M | $364.4M | $384.3M | $402.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $47M | $50.7M | $49.9M | $49.1M | $49.4M | |
| Gross Profit | $276.6M | $296.2M | $314.5M | $335.2M | $352.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $20.3M | $22.9M | $24.2M | $24.8M | $26M | |
| Selling, General & Admin | $45.9M | $48.5M | $49M | $51.5M | $55.7M | |
| Other Inc / (Exp) | $400K | -- | $600K | $1.9M | -$400K | |
| Operating Expenses | $66.2M | $71.4M | $73.2M | $76.3M | $81.7M | |
| Operating Income | $210.4M | $224.8M | $241.3M | $258.9M | $271.2M | |
| Net Interest Expenses | $22.5M | $18.5M | $8.1M | $6.8M | $12.4M | |
| EBT. Incl. Unusual Items | $188.3M | $206.3M | $233.8M | $254M | $258.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $37.9M | $48.8M | $55.1M | $59.9M | $59.1M | |
| Net Income to Company | $150.4M | $157.5M | $178.7M | $194.1M | $199.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $150.4M | $157.5M | $178.7M | $194.1M | $199.3M | |
| Basic EPS (Cont. Ops) | $1.33 | $1.43 | $1.70 | $1.93 | $2.11 | |
| Diluted EPS (Cont. Ops) | $1.33 | $1.43 | $1.70 | $1.92 | $2.10 | |
| Weighted Average Basic Share | $113.1M | $110.2M | $104.9M | $100.8M | $94.6M | |
| Weighted Average Diluted Share | $113.3M | $110.3M | $105M | $100.9M | $94.8M | |
| EBITDA | $222.4M | $237M | $264.2M | $282.6M | $287.6M | |
| EBIT | $210.8M | $225.1M | $252.6M | $272.8M | $278.7M | |
| Revenue (Reported) | $323.6M | $346.9M | $364.4M | $384.3M | $402.3M | |
| Operating Income (Reported) | $210.4M | $224.8M | $241.3M | $258.9M | $271.2M | |
| Operating Income (Adjusted) | $210.8M | $225.1M | $252.6M | $272.8M | $278.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $401.2M | $223.5M | $373.6M | $240.1M | $206.7M | |
| Short Term Investments | $765.7M | $982.3M | $606.8M | $686.3M | $393.2M | |
| Accounts Receivable, Net | $4.6M | $5.3M | $6.2M | $6.3M | $5.6M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $40.6M | $49M | $48.8M | $47.1M | $55.1M | |
| Other Current Assets | $2.2M | $900K | $1.4M | $1.2M | $1M | |
| Total Current Assets | $1.2B | $1.3B | $1B | $988.3M | $663.8M | |
| Property Plant And Equipment | $256.8M | $259.6M | $239.2M | $240.6M | $233.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $52.5M | $52.5M | $52.5M | $52.5M | $52.5M | |
| Other Intangibles | $145M | $145M | $145M | $145M | $145M | |
| Other Long-Term Assets | $11.6M | $7.6M | $7.7M | $8.5M | $8.4M | |
| Total Assets | $1.8B | $2B | $1.7B | $1.7B | $1.4B | |
| Accounts Payable | $12.3M | $9M | $9.8M | $12.5M | $10.6M | |
| Accrued Expenses | $48.3M | $41.7M | $35.6M | $34.7M | $34.7M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $299.8M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $5.5M | $5.1M | $5.2M | |
| Other Current Liabilities | -- | -- | $100K | $10.7M | $1.1M | |
| Total Current Liabilities | $988.7M | $1.1B | $1.1B | $1.2B | $1.5B | |
| Long-Term Debt | $1.8B | $1.8B | $1.8B | $1.8B | $1.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.2B | $3.2B | $3.3B | $3.3B | $3.4B | |
| Common Stock | $14.3B | $13.6B | $12.6B | $11.8B | $10.6B | |
| Other Common Equity Adj | -$2.8M | -$2.8M | -$2.7M | -$2.6M | -$2.5M | |
| Common Equity | -$1.4B | -$1.3B | -$1.6B | -$1.6B | -$2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$1.4B | -$1.3B | -$1.6B | -$1.6B | -$2B | |
| Total Liabilities and Equity | $1.8B | $2B | $1.7B | $1.7B | $1.4B | |
| Cash and Short Terms | $1.2B | $1.2B | $980.4M | $926.4M | $599.9M | |
| Total Debt | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $246.8M | $758.5M | $819.8M | $731.8M | $575.4M | |
| Short Term Investments | $934.4M | $451.1M | $195.2M | $192.9M | $73.1M | |
| Accounts Receivable, Net | $5.1M | $5.2M | -- | $6.5M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $46.5M | $50.3M | -- | $49.4M | -- | |
| Other Current Assets | $1.5M | $1.1M | $58.1M | $1M | $65.6M | |
| Total Current Assets | $1.2B | $1.3B | $1.1B | $988.3M | $714.1M | |
| Property Plant And Equipment | $252.1M | $252.2M | $224.9M | $234.6M | $221.5M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $52.5M | $52.5M | $52.5M | $52.5M | $52.5M | |
| Other Intangibles | $145M | -- | -- | -- | $145M | |
| Other Long-Term Assets | $10.6M | $7.6M | $28.9M | $8.7M | $37.4M | |
| Total Assets | $1.8B | $2B | $1.8B | $1.7B | $1.4B | |
| Accounts Payable | $11.3M | $7.4M | $6.6M | $9.4M | $9.6M | |
| Accrued Expenses | $57.1M | $47.1M | $46.9M | $40.5M | $29.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $5M | $5.4M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1B | $1.1B | $1.2B | $1.2B | $1.3B | |
| Long-Term Debt | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.2B | $3.3B | $3.4B | $3.4B | $3.4B | |
| Common Stock | $14.1B | $13.4B | $12.4B | $11.6B | $10.4B | |
| Other Common Equity Adj | -$2.7M | -$3M | -$2.7M | -$2.8M | -$2.8M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$1.4B | -$1.3B | -$1.6B | -$1.6B | -$2B | |
| Total Liabilities and Equity | $1.8B | $2B | $1.8B | $1.7B | $1.4B | |
| Cash and Short Terms | $1.2B | $1.2B | $1B | $924.7M | $648.5M | |
| Total Debt | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $814.9M | $784.8M | $673.8M | $817.6M | $785.7M | |
| Depreciation & Amoritzation | $46.4M | $47.9M | $46.9M | $44.1M | $36.9M | |
| Stock-Based Compensation | $48.2M | $53.4M | $58.6M | $59.7M | $61.1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $730.2M | $807.2M | $831.1M | $853.8M | $902.6M | |
| Capital Expenditures | $43.4M | $53M | $27.4M | $45.8M | $28.1M | |
| Cash Acquisitions | $20.8M | -- | -- | -- | -- | |
| Cash From Investing | -$72.3M | -$269.2M | $355.7M | -$97.4M | $286.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $741.1M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$750M | -- | -- | -- | |
| Repurchase of Common Stock | -$777.5M | -$722.6M | -$1B | -$901.4M | -$1.2B | |
| Other Financing Activities | -- | -- | -- | -$700K | -$8.2M | |
| Cash From Financing | -$764.9M | -$719.1M | -$1B | -$889.8M | -$1.2B | |
| Beginning Cash (CF) | $517.6M | $410.6M | $228.8M | $379M | $245.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$107M | -$181.1M | $151M | -$133.4M | -$32.6M | |
| Ending Cash (CF) | $410.6M | $228.8M | $379M | $245.5M | $212.1M | |
| Levered Free Cash Flow | $686.8M | $754.2M | $803.7M | $808M | $874.5M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $147.7M | $167.3M | $185.7M | $198.8M | -- | |
| Depreciation & Amoritzation | $12M | $11.9M | $11.3M | $9.3M | -- | |
| Stock-Based Compensation | $13.6M | $13.7M | $15.7M | $14.3M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $142.5M | $144.9M | $145.3M | $160.4M | -- | |
| Capital Expenditures | $17.6M | $6.2M | $6.5M | $9.2M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $10.3M | $54.9M | -$398.3M | -$249.9M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $742.3M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$750M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$175.8M | -$351.5M | -$222.9M | -$390.3M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$183.5M | -$351.5M | -$222.9M | -$390.3M | -- | |
| Beginning Cash (CF) | $256.2M | $763.9M | $825.1M | $737.2M | -- | |
| Foreign Exchange Rate Adjustment | -$100K | -$600K | -- | $100K | -- | |
| Additions / Reductions | -$30.7M | -$151.7M | -$475.9M | -$479.8M | -- | |
| Ending Cash (CF) | $225.4M | $611.6M | $349.2M | $257.5M | -- | |
| Levered Free Cash Flow | $124.9M | $138.7M | $138.8M | $151.2M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $631.2M | $791.9M | $695M | $833M | $790.9M | |
| Depreciation & Amoritzation | $46.7M | $48.2M | $46.6M | $42.3M | $36M | |
| Stock-Based Compensation | $49.8M | $54.6M | $58.2M | $61M | $63.5M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $748.4M | $816M | $883M | $852.1M | $936.6M | |
| Capital Expenditures | $39.1M | $52.9M | $26.5M | $43.9M | $30.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$326.5M | $430.5M | $241M | -$10.8M | $107.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$687.2M | -$741.8M | -$1.1B | -$940.8M | -$1.2B | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$674.9M | -$738.2M | -$1.1B | -$928.9M | -$1.2B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$253M | $508.3M | $62.1M | -$87.6M | -$155.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $709.3M | $763.1M | $856.5M | $808.2M | $906.5M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $298.1M | $324.8M | $364.4M | $392.9M | $199.3M | |
| Depreciation & Amoritzation | $23.6M | $23.8M | $22.9M | $19.1M | $8.9M | |
| Stock-Based Compensation | $26.6M | $27.9M | $29.5M | $29.4M | $17.5M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $340.8M | $352M | $404.3M | $417.7M | $291.3M | |
| Capital Expenditures | $24.3M | $12.8M | $12.2M | $13M | $5.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$164.9M | $579.4M | $11.5M | $246.5M | $317.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $742.3M | -- | -- | -- | $493.9M | |
| Long-Term Debt Repaid | -$750M | -- | -- | -- | -$500M | |
| Repurchase of Common Stock | -$361.2M | -$556.1M | -$453.4M | -$660.2M | -$241.7M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$360.8M | -$547.9M | -$445.4M | -$651.9M | -$239.9M | |
| Beginning Cash (CF) | $666.8M | $992.7M | $1.2B | $982.7M | $212.1M | |
| Foreign Exchange Rate Adjustment | -$300K | -$700K | -$200K | -$300K | -$300K | |
| Additions / Reductions | -$184.9M | $383.5M | -$29.6M | $12.3M | $369M | |
| Ending Cash (CF) | $481.6M | $1.4B | $1.2B | $994.7M | $580.8M | |
| Levered Free Cash Flow | $316.5M | $339.2M | $392.1M | $404.7M | $285.5M | |
Get VRSN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VRSN
Sector
P/E ratio
34.63x
23.84x
PEG ratio
70.47x
0.00x
P/B ratio
--
2.31x
Price / LTM sales
17.38x
1.64x
Growth Metrics
VRSN
Sector
Revenue growth
4.68%
3.84%
Earnings growth
9.38%
10.8%
Revenue (5-year growth)
4.81%
6.27%
Earnings forecast
$2.20
$0.12
Profitability
VRSN
Sector
Profitability FY 2024
$1.4B
$77.3M
Return on invested capital
6062.5%
0.05%
Return on assets
52.38%
-0.48%
Return on equity
--
0.73%
Earnings Date
Last Earnings Date
Apr
24
Next Earnings Date
Jul
24
Estimated Next Earnings Date
Jul
24
Balance Sheet
VRSN
Sector
Total cash
$648.5M
$48.7M
Short term investments
$393.2M
$19.4M
Total assets
$1.4B
$223.8M
Long term debt
$1.8B
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
